Difference between revisions of "PRIMARY HYPERTENSION"
(Imported from text file) |
|||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
===== [[Summary Article|'''SUMMARY''']] ===== | ===== [[Summary Article|'''SUMMARY''']] ===== | ||
1. 95% of all HTN is primary (i.e., essential, idiopathic). | 1. 95% of all HTN is primary (i.e., essential, idiopathic). | ||
<br/>2. The systolic blood pressure (SBP) and diastolic blood pressure (DBP) define the stages of HTN (the average of >2 readings taken from each of >2 visits after the initial screening). | <br/> | ||
<br/>2. The systolic blood pressure (SBP) and diastolic blood pressure (DBP) define the stages of HTN (the average of > 2 readings taken from each of > 2 visits after the initial screening). | |||
<br/> | <br/> | ||
<br/>3. Threshold for pharmacologic treatment are defined in JNC 8 based on age, diabetes, and CKD: | <br/>3. Threshold for pharmacologic treatment are defined in JNC 8 based on age, diabetes, and CKD: | ||
<br/>• General population < 60 years: < 140/90 | <br/>• General population < 60 years: < 140/90 mmHg | ||
<br/>• General population > 60 years: < 150/90 | <br/>• General population > 60 years: < 150/90 mmHg | ||
<br/>• All ages, if CKD or diabetes: < 140/90 | <br/>• All ages, if CKD or diabetes: < 140/90 mmHg | ||
<br/> | <br/> | ||
<br/>4. Goal: SBP < 150 mmHg and DBP < 90 mmHg, which reduces stroke, heart failure, and CHD. Strong Recommendation Grade A. | <br/>4. Goal: SBP < 150 mmHg and DBP < 90 mmHg, which reduces stroke, heart failure, and CHD. Strong Recommendation, Grade A. | ||
==Reference(s)== | ==Reference(s)== | ||
Wilkinson, I. (2017). Oxford handbook of clinical medicine. Oxford: Oxford University Press. | Wilkinson, I., Furmedge, D. and Sinharay, R. (2017). Oxford handbook of clinical medicine. Oxford: Oxford University Press. [https://amzn.to/3YHrI6K Get it on Amazon.] | ||
<br/>Feather, A., Randall, D. and Waterhouse, M. (2020). Kumar And Clark’s Clinical Medicine. 10th ed. S.L.: Elsevier Health Sciences. [https://amzn.to/3k7WSW0 Get it on Amazon.] | |||
<br/>Hannaman, R. A., Bullock, L., Hatchell, C. A., & Yoffe, M. (2016). Internal medicine review core curriculum, 2017-2018. CO Springs, CO: MedStudy. | <br/>Hannaman, R. A., Bullock, L., Hatchell, C. A., & Yoffe, M. (2016). Internal medicine review core curriculum, 2017-2018. CO Springs, CO: MedStudy. | ||
<br/>Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited. https://www.tg.org.au [Accessed 2021]. | <br/>Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited. https://www.tg.org.au [Accessed 2021]. | ||
Latest revision as of 00:08, 14 March 2023
SUMMARY
1. 95% of all HTN is primary (i.e., essential, idiopathic).
2. The systolic blood pressure (SBP) and diastolic blood pressure (DBP) define the stages of HTN (the average of > 2 readings taken from each of > 2 visits after the initial screening).
3. Threshold for pharmacologic treatment are defined in JNC 8 based on age, diabetes, and CKD:
• General population < 60 years: < 140/90 mmHg
• General population > 60 years: < 150/90 mmHg
• All ages, if CKD or diabetes: < 140/90 mmHg
4. Goal: SBP < 150 mmHg and DBP < 90 mmHg, which reduces stroke, heart failure, and CHD. Strong Recommendation, Grade A.
Reference(s)
Wilkinson, I., Furmedge, D. and Sinharay, R. (2017). Oxford handbook of clinical medicine. Oxford: Oxford University Press. Get it on Amazon.
Feather, A., Randall, D. and Waterhouse, M. (2020). Kumar And Clark’s Clinical Medicine. 10th ed. S.L.: Elsevier Health Sciences. Get it on Amazon.
Hannaman, R. A., Bullock, L., Hatchell, C. A., & Yoffe, M. (2016). Internal medicine review core curriculum, 2017-2018. CO Springs, CO: MedStudy.
Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited. https://www.tg.org.au [Accessed 2021].
